| SCCmec III | SCCmec IV | SCCmec V | Untypeable | Total |
---|---|---|---|---|---|
 | N = 60 (%) | N = 27 (%) | N = 2 (%) | N = 2 (%) | N = 91 (%) |
Age | |||||
  ≤ 50 years old | 12 (20) | 3 (11.1) | 0 (0) | 0 (0) | 15 (16.5) |
  > 50 years old | 47 (78.3) | 23 (85.2) | 2 (100) | 2 (100) | 74 (81.3) |
 Not Known | 1 (1.7) | 1 (3.7) | 0 (0) | 0 (0) | 2 (2.2) |
Gender | |||||
 Female | 30 (50) | 10 (37) | 0 (0) | 0 (0) | 40 (43.9) |
 Male | 29 (48.3) | 16 (59.3) | 2 (100) | 2 (100) | 49 (53.8) |
 Not Known | 1 (1.7) | 1 (3.7) | 0 (0) | 0 (0) | 2 (2.2) |
Co-morbidities | |||||
 Diabetes mellitus | 20 (33.3) | 11 (40.7) | 1 (50) | 0 (0) | 32 (35.2) |
 Hypertension | 22 (36.7) | 12 (44.4) | 1 (50) | 0 (0) | 35 (38.5) |
 Obesity | 0 (0) | 1 (3.7) | 0 (0) | 0 (0) | 1 (1.1) |
 Chronic kidney disease and UTI | 24 (40) | 14 (51.9) | 0 (0) | 0 (0) | 38 (41.8) |
 Cancer | 8 (13.3) | 2 (7.4) | 0 (0) | 0 (0) | 10 (10.9) |
 Head injury | 11 (18.3) | 4 (14.8) | 0 (0) | 1 (50) | 16 (17.6) |
 Liver disease | 4 (6.7) | 2 (7.4) | 0 (0) | 0 (0) | 6 (6.6) |
 Respiratory disease | 12 (20) | 3 (11.1) | 1 (50) | 0 (0) | 16 (17.6) |
 Cardiovascular disease | 4 (6.7) | 8 (29.6) | 2 (100) | 0 (0) | 14 (15.4) |
 Gastrointestinal disease | 4 (6.7) | 1 (3.7) | 0 (0) | 0 (0) | 5 (5.5) |
 Autoimmune disease | 1 (1.7) | 0 (0) | 0 (0) | 0 (0) | 1 (1.1) |
 Bone and joint disorder | 1 (1.7) | 2 (7.4) | 0 (0) | 0 (0) | 3 (3.3) |
 Endocrine disorder | 0 (0) | 2 (7.4) | 0 (0) | 0 (0) | 2 (2.2) |
 Blood disorder | 2 (3.3) | 0 (0) | 0 (0) | 0 (0) | 2 (2.2) |
 CMV | 1 (1.7) | 0 (0) | 0 (0) | 0 (0) | 1 (1.1) |
 Skin disease | 7 (11.7) | 0 (0) | 0 (0) | 0 (0) | 7 (7.7) |
 None | 1 (1.7) | 0 (0) | 0 (0) | 0 (0) | 1 (1.1) |
 Not known | 7 (11.7) | 5 (18.5) | 0 (0) | 1 (50) | 13 (14.3) |
No of comorbidities | |||||
 0 | 8 (13.3) | 5 (18.5) | 0 (0) | 1 (50) | 14 (15.4) |
 1 | 19 (31.7) | 5 (18.5) | 1 (50) | 1 (50) | 26 (28.6) |
 2 | 11 (18.3) | 6 (22.2) | 0 (0) | 0 (0) | 17 (18.7) |
 3 | 12 (20) | 1 (3.7) | 0 (0) | 0 (0) | 13 (14.3) |
 ≥ 4 | 10 (16.7) | 10 (37) | 1 (50) | 0 (0) | 21 (23.1) |
Source of bacteraemia | |||||
 Primary bacteraemia | 38 (63.3) | 19 (70.4) | 2 (100) | 2 (100) | 61 (67) |
 Catheter-related | 7 (11.7) | 5 (18.5) | 0 (0) | 0 (0) | 12 (13.2) |
 Skin and soft tissue infection | 6 (10) | 0 (0) | 0 (0) | 0 (0) | 6 (6.6) |
 Surgical site infection | 1 (1.7) | 0 (0) | 0 (0) | 0 (0) | 1 (1.1) |
 Pneumonia | 5 (8.3) | 2 (7.4) | 0 (0) | 0 (0) | 7 (7.7) |
 Implant-related infection | 0 (0) | 1 (3.7) | 0 (0) | 0 (0) | 1 (1.1) |
 More than one source | 3 (5) | 0 (0) | 0 (0) | 0 (0) | 3 (3.3) |
Type of MRSA | |||||
 HA-MRSA | 36 (60) | 15 (55.6) | 0 (0) | 0 (0) | 51 (56) |
 CA-MRSA | 15 (25) | 9 (33.3) | 2 (100) | 1 (50) | 27 (29.7) |
 Not Known | 9 (15) | 3 (11.1) | 0 (0) | 1 (50) | 13 (14.3) |
CC/ST | |||||
  CC1 | |||||
  ST1 | 0 (0) | 1 (3.7) | 0 (0) | 0 (0) | 1 (1.1) |
  ST772 | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 1 (1.1) |
  CC5 | |||||
  ST5 | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 1 (1.1) |
  CC6 | |||||
  ST6 | 0 (0) | 6 (22.2) | 0 (0) | 0 (0) | 6 (6.6) |
  CC8 | |||||
  ST239 | 60 (100) | 0 (0) | 0 (0) | 1 (50) | 61 (67) |
  CC22 | |||||
  ST22 | 0 (0) | 19 (70.4) | 0 (0) | 0 (0) | 19 (20.9) |
  ST1137 | 0 (0) | 1 (3.7) | 0 (0) | 0 (0) | 1 (1.1) |
  CC45 | |||||
  ST508 | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 1 (1.1) |
Vancomycin MIC | |||||
  < 1.5 μg/mL | 22 (36.7) | 25 (92.6) | 1 (50) | 1 (50) | 49 (53.8) |
  ≥ 1.5 μg/mL | 38 (63.3) | 2 (7.4) | 1 (50) | 1 (50) | 42 (46.2) |